Browse By Topic and Related Items

Topic Browser

Related Items

Bookmark and Share

In the Literature: Research You Need to Know

From: The eWire, 10.21.09

Use of acid-suppressive medication is associated with increased risk of hospital-acquired pneumonia

Clinical question: Is the use of acid-suppressive medications associated with increased risk of hospital-acquired pneumonia (HAP) in nonventilated inpatients?

Background: Acid-suppressive medications are used frequently in the hospital setting, even though their use often is not evidence-based. Data suggests an association between acid-suppressive medication use and community-acquired pneumonia in the outpatient setting.

Study design: Prospective pharmacoepidemiologic cohort study.

Setting: Large urban academic medical center in Boston.

Synopsis: The cohort was 63,878 admissions of nonventilated patients hospitalized for at least three days. Acid-suppressive medications were prescribed in 52% of admissions; HAP occurred in 3.5% of admissions.

The unadjusted HAP incidence was higher in the group exposed to acid-suppressive medication, compared with the unexposed group (4.9% vs. 2.0%). After adjustment, the likelihood of HAP increased with the use of acid-suppressive medication (adjusted odds ratio, (95% C.I.), 1.3, (1.1 vs. 1.4)).

The matched propensity score analyses and sensitivity analyses yielded similar results. The relationship appeared slightly stronger for aspiration pneumonia compared with nonaspiration pneumonia.

When stratified by type of acid-suppressive medication, proton-pump inhibitors were associated with increased odds of HAP (AOR, (95% C.I.), 1.3 (1.1-1.4)), but histamine receptor antagonists were not (AOR, (95% C.I.), 1.2 (0.98-1.4).

This study was not powered appropriately to detect significance for an OR less than 1.3.

Bottom line: The use of acid-suppressive medications is associated with increased odds of HAP in nonventilated hospitalized patients.

Reference: Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301(20):2120-2128.

Reviewed for TH eWire by Alexander R. Carbo, MD, FHM; Suzanne Bertisch, MD, MPH; Lauren Doctoroff, MD; John Fani Srour, MD; Caleb Hale, MD; Nancy Torres-Finnerty, MD, FHM, Hospital Medicine Program, Beth Israel Deaconess Medical Center, Boston

This copy is for your personal, noncommercial use only. No part of this article can be reproduced without the written permission of the publisher. Order presentation-ready copies for distribution to your colleagues, clients, or customers by contacting our reprints department at Copyright © 2009 Society of Hospital Medicine, administered by John Wiley & Sons Inc.

current issue

October 2014


The Hospitalist newsmagazine reports on issues and trends in hospital medicine. The Hospitalist reaches more than 25,000 hospitalists, physician assistants, nurse practitioners, residents, and medical administrators interested in the practice and business of hospital medicine.

Copyright © 2000–2014 by John Wiley & Sons, Inc. or related companies. All rights reserved.

ISSN: 1553-085X